Published September 15, 2007 | Version v1
Journal article

Methamphetamine and 3,4-methylenedioxymethamphetamine interact with central nicotinic receptors and induce their up-regulation

  • 1. Unitat de Farmacologia i Farmacognosia, Facultat de Farmacia, Nucli Universitari de Pedralbes, Universitat de Barcelona, 08028 Barcelona (Spain)

Description

Previous work from our group indicated that α7 nicotinic acetylcholine receptors (α7 nAChR) potentially play a role in methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA) neurotoxicity. The aims of the present study were two-fold: (1) to demonstrate the interaction of METH and MDMA with homomeric α7 nAChR ([3H]methyllycaconitine binding) and other heteromeric subtypes ([3H]epibatidine binding); and (2) to show the effects of amphetamine derivative pretreatment on the density of binding sites. METH and MDMA displaced [3H]methyllycaconitine and [3H]epibatidine binding in membranes from NGF-differentiated PC 12 cells and mouse brain, with Ki values in the micromolar range, MDMA revealing a greater affinity than METH. In addition, METH and MDMA induced a time- and concentration-dependent increase in [3H]methyllycaconitine and [3H]epibatidine binding; which had already been apparent after 6 h of pretreatment, and which peaked in differentiated PC 12 cells after 48 h. The highest increases were found in [3H]epibatidine binding, with MDMA inducing higher increases than METH. Treatment with METH and MDMA increased Bmax of high-affinity sites for both radioligands without affecting Kd. The heightened binding was inhibited by pretreatment with cycloheximide, suggesting the participation of newly synthesised proteins while inhibition of protein trafficking to plasma membrane did not block up-regulation. The effects of protein kinase and cyclophilin inhibitors on such up-regulation were explored, revealing a rapid, differential and complex regulation, similar to that described for nicotinic ligands. All of these results demonstrate that METH and MDMA have affinity for, and can interact with, nAChR, inducing their up-regulation, specially when higher doses are used. Such effects may have a role in METH- and MDMA-induced neurotoxicity, cholinergic neurotransmission, and in processes related to addiction and dependence

Availability note (English)

Available from http://dx.doi.org/10.1016/j.taap.2007.05.015

Additional details

Identifiers

DOI
10.1016/j.taap.2007.05.015;
PII
S0041-008X(07)00245-1;

Publishing Information

Journal Title
Toxicology and Applied Pharmacology
Journal Volume
223
Journal Issue
3
Journal Page Range
p. 195-205
ISSN
0041-008X
CODEN
TXAPA9

Optional Information

Copyright
Copyright (c) 2007 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.